1. Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic

   • Tiago Torres
   • Luis Puig

   Current Opinion 10 April 2020 Pages: 307 - 311

2. When is it OK to Stop Anti-Programmed Death 1 Receptor (PD-1) Therapy in Metastatic Melanoma?

   • Lauren B. Banks
   • Ryan J. Sullivan

   Current Opinion 05 February 2020 Pages: 313 - 321

3. Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative

   • Lourdes M. Perez-Chada
   • Nicole F. Salame
   • April W. Armstrong

   Systematic Review 16 January 2020 Pages: 323 - 338

   

4. Dermatomyositis: An Update on Diagnosis and Treatment

   • Gabriela A. Cobos
   • Alisa Femia
   • Ruth Ann Vleugels

   Review Article 24 February 2020 Pages: 339 - 353

   

5. Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments

   • Magdalena Misiak-Galazka
   • Joanna Zozula
   • Lidia Rudnicka

   Review Article Open access 01 February 2020 Pages: 355 - 370

6. Conjunctival Melanoma: Current Treatments and Future Options

   • Joseph M. Grimes
   • Nirav V. Shah
   • Brian P. Marr

   Review Article 21 January 2020 Pages: 371 - 381

   

7. Non-Classic Signs of Sézary Syndrome: A Review

   • Lisa Morris
   • Jessica Tran
   • Madeleine Duvic

   Review Article 17 January 2020 Pages: 383 - 391

   

8. Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption

   • Shreya Patel
   • Ann M. John
   • Robert A. Schwartz

   Review Article 30 January 2020 Pages: 393 - 399

   

9. Sensitive Skin Syndrome: An Update

   • Le Hanh Dung Do
   • Nazanin Azizi
   • Howard Maibach

   Review Article 13 December 2019 Pages: 401 - 409

10. Optimizing Isotretinoin Treatment of Acne: Update on Current Recommendations for Monitoring, Dosing, Safety, Adverse Effects, Compliance, and Outcomes

    • Megan N. Landis

    Therapy in Practice 27 February 2020 Pages: 411 - 419

    

11. Malignancy Rates in Brodalumab Clinical Studies for Psoriasis

    • Alice Gottlieb
    • Mark Lebwohl
    • Abby Jacobson

    Original Research Article Open access 23 March 2020 Pages: 421 - 430

    

12. Risk for Suicidal Behavior Among Psoriasis Patients: A Nationwide Cohort Study

    • Shu-Hui Wang
    • Jui Wang
    • Tao-Hsin Tung

    Original Research Article 28 November 2019 Pages: 431 - 439

    

13. Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study

    • Andrea Chiricozzi
    • Martina Burlando
    • Anna Balato

    Short Communication 30 November 2019 Pages: 441 - 447

    

14. Topical Minocycline Foam 4%: A Review in Acne Vulgaris

    • Julia Paik

    Adis Drug Evaluation 28 May 2020 Pages: 449 - 456